Bending Spoons skyrockets 35% as Berkshire Hathaway makes $330 million investment

Bending Spoons shares surged 35% after a filing disclosed a new $330 million Berkshire Hathaway investment, following Berkshire’s $600 million investment in July. Bending Spoons will issue 10 million ordinary shares at $33 each, bringing Berkshire’s stake to 4%. The company said the investment adds financial flexibility to pursue acquisitions and that its M&A pipeline remains strong.

Analysis

The key read-through is financing optionality, not Berkshire’s endorsement as a substitute for diligence. A 4% holding does not confer control; the more consequential question is whether Bending Spoons can turn new capital into acquisitions that improve per-share economics rather than simply expand its portfolio. More available capital can also intensify bidding for digital businesses, raising purchase multiples and making disciplined returns harder to achieve. The share issuance is dilutive, but its per-share effect cannot be assessed without the pre-deal share count and a clear use-of-proceeds plan.

Near term, the 35% move raises the risk that investors have priced in acquisition upside before any acquired earnings are visible. Over 1–3 months, watch for announced deals, funding terms, and evidence of integration or cash-flow contribution. Over 6–18 months, the thesis hinges on acquisition returns and financing discipline. For Berkshire Hathaway, the position is not by itself evidence of a material change in consolidated earnings exposure or a broader shift in capital allocation under Greg Abel.

Contrarian angle: capital access may be treated as an unambiguous positive, when it can also inflate deal prices and dilute returns. The thesis weakens if Bending Spoons pursues large or frequent acquisitions without transparent per-share performance measures; it strengthens if subsequent deals show cash-flow accretion without escalating financing risk.

Key Decisions for Investors

• BSP: Do not chase the sharp initial repricing. First compare the live share price with the $33 issuance price and verify the pre- and post-issuance share count; the article does not provide enough information to judge valuation or dilution. Reassess after the initial event-driven flows settle.
• BSP watch item: Require acquisition-level disclosure—purchase consideration, funding mix, and subsequent cash-flow contribution—before treating the stronger pipeline as earnings growth. Negative evidence would be repeated acquisitions without measurable per-share cash-flow progress over the next 6–18 months.
• BRK.A: No standalone trade on this investment alone. Track any follow-on commitment or broader change in disclosed capital-allocation behavior; this transaction’s strategic importance to Berkshire is not established by the filing described.
• Risk control: The positive BSP thesis is falsified by a sharp deterioration in financing terms, material dilution beyond this issuance, or acquisitions that fail to contribute cash flow; absent those signals, treat the news as improved funding capacity rather than proof of value creation.